Maartje S Jacobs (M S Jacobs)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Venues

Journal of medical economics

The European journal of health economics : HEPAC : health economics in prevention and care

Open heart

European heart journal. Quality of care & clinical outcomes

Rijksuniversiteit Groningen

Rijksuniversiteit Groningen (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rijksuniversiteit Groningen

Netherlands

PhD student :: PharmacoTherapy, -Epidemiology & -Economics (PTEE)

Martini Ziekenhuis

Netherlands

Pharmacist :: Clinical Pharmacy and Toxicology

Education History

Rijksuniversiteit Groningen

Netherlands

MSC :: Pharmacy

Publications

Marinus H van Hulst, Robert G Tieleman, Lennaert A R Zwart, Marc Pomp, Maartje S Jacobs, Joan G Meeder, Clara E E van Ofwegen-Hanekamp, Monika Hollander, Paul Smits, Martin E W Hemels
Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands. European heart journal. Quality of care & clinical outcomes (2022)
Maartje S Jacobs, Bert Loef, Auke C Reidinga, Maarten J Postma, Marinus Van Hulst, Robert G Tieleman
Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit. Open heart 7 (1) (2020)
Maartje S Jacobs, Jeroen F Schouten, Pieter T de Boer, Mikael Hoffmann, Lars-Åke Levin, Maarten Jacobus Postma
Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands. Current medical research and opinion 34 (10) (2018)
Maartje S Jacobs, M W J van Leent, R G Tieleman, F G A Jansman, Q Cao, Maarten Jacobus Postma, M van Hulst
Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands. Journal of medical economics 20 (12) (2017)
Maartje S Jacobs, Lisa A de Jong, Maarten J Postma, Robert G Tieleman, Marinus van Hulst
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation. The European journal of health economics : HEPAC : health economics in prevention and care 19 (7) (2017)
Marinus H van Hulst, Jelena Stevanovic, Maartje S Jacobs, Robert G Tieleman, Bregt Kappelhoff, Maarten J Postma
The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands. Journal of medical economics 21 (1) (2017)

Maartje S Jacobs.css-eqlu8i{font-size:small;padding-left:4px;} (M S Jacobs)

Publication Activity (10 Years)

Top Topics

Top Venues

Maartje S Jacobs (M S Jacobs)